SIBIA Neurosciences (SIBI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SIBIA Neurosciences (SIBI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rick Costantino who wrote (114)	11/17/1997 1:20:00 PM
From: scaram(o)uche	Read Replies (1) of 579

Rick: Can't answer your question. However, it looked like someone dumping a moderate position into (the usual) thin trading. That is, it looks like someone was willing to bail at any cost. I was too busy (moving) to take advantage of it. Again, my position on SIBI..... tough to buy this much good science at this differential between market cap and cash. However, neurochemicals are crap-shoots. If any one of the partnered projects hits (including anything from Lilly, which, despite the positive spin following cancelation of the collaboration, I consider as unlikely), the current market cap is justified. If any one of the unpartnered projects shows promise, the stock is a screaming buy. Given the support lent by the screening-related technolgies, I still consider SIBI as a great addition to a high-risk portfolio. Salk's desire to bail has not affected my opinion. Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next